Dg. Simonsmorton et al., RAPID EARLY ACTION FOR CORONARY TREATMENT - RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS, Academic emergency medicine, 5(7), 1998, pp. 726-738
Objective: Early reperfusion for acute myocardial infarction (AMI) can
reduce morbidity and mortality, yet there is often delay in accessing
medical care after symptom onset. This report describes the design an
d baseline characteristics of the Rapid Early Action for Coronary Trea
tment (REACT) community trial, which is testing community intervention
to reduce delay. Methods: Twenty U.S. communities were pair-matched a
nd randomly assigned within pairs to intervention or comparison. Four
months of baseline data collection was followed by an 18-month interve
ntion of community organization and public, patient, and health profes
sional education. Primary cases were community residents seen in the E
D with chest pain, admitted with suspected acute cardiac ischemia, and
discharged with a diagnosis related to coronary heart disease. The pr
imary outcome was delay time from symptom onset to ED arrival. Seconda
ry outcomes included delay time in patients with MI/unstable angina, h
ospital case-fatality rate and length of stay, receipt of reperfusion,
and ED/emergency medical services utilization. Impact on public and p
atient knowledge, attitudes, and intentions was measured by telephone
interviews. Characteristics of communities and cases and comparability
of paired communities at baseline were assessed. Results: Baseline ca
ses are 46% female, 14% minorities, and 73% aged greater than or equal
to 55 years, and paired communities have similar demographics charact
eristics. Median delay time (available for 72% of cases) is 2.3 hours
and does not vary between treatment conditions (p > 0.86). Conclusions
: REACT communities approximate the demographic distribution of the Un
ited States and there is baseline comparability between the interventi
on and comparison groups. The REACT trial will provide valuable inform
ation for community educational programs to reduce patient delay for A
MI symptoms.